Biolidics
VerifiedA Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment.
Launch date
Employees
Market cap
SGD9.3m
Net debt
(SGD1.8m)
Enterprise valuation
$8m (Public information from May 2024)
Share price
SGD0.01 8YY.SI
Singapore Singapore (HQ)
Authorizing premium user...